关于我们
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading MAGELLAN? Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu? Bone Graft Extender & Substitute; Influx?, a natural bone-graft material; and CellPoint?, a concentrated bone marrow aspirate system.
- 网站
-
https://www.istobiologics.com
Arteriocyte (Now Isto Biologics)的外部链接
- 所属行业
- 医疗设备
- 规模
- 51-200 人
- 类型
- 私人持股
- 领域
- Platelet Rich Plasma